About This Study
The purpose of this study is to learn if a new CAR T-cell treatment called AZD0120 is safe and works better than standard treatments for multiple myeloma that has come back or stopped responding to treatment. Participants will receive either AZD0120 or one of several standard treatments. This study is for volunteers diagnosed with multiple myeloma that has come back or stopped responding to treatment and have received 1 to 3 previous treatments.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC